138 related articles for article (PubMed ID: 28719449)
1. 68Ga-DOTATATE Uptake in Solitary Pancreatic Metastasis From Clear Cell Renal Cancer.
Vamadevan S; Le K; Shen L; Loh H; Mansberg R
Clin Nucl Med; 2017 Sep; 42(9):700-701. PubMed ID: 28719449
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-DOTATATE Uptake in Pancreatic Metastasis of Renal Cell Carcinoma Mimicking Pancreatic Neuroendocrine Tumor.
Soydal C; Nak D; Araz M; Demirkazik A; Kucuk NO
Clin Nucl Med; 2019 Oct; 44(10):795-796. PubMed ID: 31306201
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTATATE Uptake in a Soft Tissue Metastasis From Clear Cell Renal Cell Cancer.
Vamadevan S; Le K; Shen L; Stevanovic A; Loh H; Mansberg R
Clin Nucl Med; 2018 Jan; 43(1):44-45. PubMed ID: 29076916
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan.
Kanthan GL; Schembri GP; Samra J; Roach P; Hsiao E
Clin Nucl Med; 2016 Jul; 41(7):583-4. PubMed ID: 27055137
[TBL] [Abstract][Full Text] [Related]
5. Solitary Contralateral Adrenal Metastasis of Renal Cell Carcinoma: 68Ga-DOTATATE PET/CT Findings.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Jan; 47(1):e41-e42. PubMed ID: 34132679
[TBL] [Abstract][Full Text] [Related]
6. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
7. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
8. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
[TBL] [Abstract][Full Text] [Related]
9. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor.
Luong TV; Iversen P; Bouchelouche K; Arveschoug AK
Clin Nucl Med; 2020 May; 45(5):379-382. PubMed ID: 32149792
[TBL] [Abstract][Full Text] [Related]
11. 68 Ga-DOTATOC PET/CT in Pancreatic Metastasis From Clear Cell Renal Cell Carcinoma.
Mansour N; Rangan K; Tiling R; Rübenthaler J; Fabritius MP
Clin Nucl Med; 2023 Aug; 48(8):712-713. PubMed ID: 37276508
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-DOTATATE Uptake in Ischemic Stroke.
Vallée É; Paquet N; Buteau JP; Turcotte É
Clin Nucl Med; 2018 Jan; 43(1):46-47. PubMed ID: 29135613
[TBL] [Abstract][Full Text] [Related]
13. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
14. Solitary Pulmonary Perivascular Epithelial Cell Tumor Mimicking Pulmonary Metastasis on 68 Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
Liang S; Chen X
Clin Nucl Med; 2024 Jun; 49(6):567-568. PubMed ID: 38631001
[TBL] [Abstract][Full Text] [Related]
15. 111In-DTPA-Octreotide SPECT (OctreoScan) Uptake in Metastatic Renal Cell Carcinoma to the Pancreas.
Chan K; Luong TV; Navalkissoor S
Clin Nucl Med; 2018 Jan; 43(1):e29-e30. PubMed ID: 29166326
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
[TBL] [Abstract][Full Text] [Related]
17. Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation.
Kuyumcu S; Özkan ZG; Sanli Y; Yilmaz E; Mudun A; Adalet I; Unal S
Ann Nucl Med; 2013 Jul; 27(6):538-45. PubMed ID: 23543506
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Insulinoma Controlled by Targeted Radionuclide Therapy With 177Lu-DOTATATE in a Patient With Solitary Kidney and MEN-1 Syndrome.
Novruzov F; Mehmetbeyli L; Aliyev JA; Abbasov B; Mehdi E
Clin Nucl Med; 2019 Jun; 44(6):e415-e417. PubMed ID: 30789400
[TBL] [Abstract][Full Text] [Related]
19. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Chen EJ; Tan TH; Chew MT; Chye PC
Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-DOTATATE PET/CT Uptake in Prostate With an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver.
Nisar MU; Costa DN; Jia L; Öz OK; de Blanche L
Clin Nucl Med; 2021 Aug; 46(8):e428-e430. PubMed ID: 34034323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
